SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-011928
Filing Date
2017-06-29
Accepted
2017-06-28 17:51:00
Documents
1
Period of Report
2017-06-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K navb20170628_8k.htm 8-K 24896
  Complete submission text file 0001437749-17-011928.txt   26054
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 17936358
SIC: 2835 In Vitro & In Vivo Diagnostic Substances